Research map: Development of a machine learning-based noninvasive diagnostic model for liver fibrosis in metabolic-associated steatotic liver disease

Back to the article

Papers in this map

  1. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases · Naga Chalasani · 2017 · 7417 citations · Cited by this paper
  2. Persistent heartburn in a multiethnic population: treatment gaps, ethnic disparities, and diagnostic yield from a large cohort · 2026 · Related
  3. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡ · Richard K. Sterling · 2006 · 5001 citations · Cited by this paper
  4. Estimated glucose disposal rate anrd mortality prediction in metabolic dysfunction–associated steatotic liver disease · 2026 · Related
  5. A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C · Chun Tao Wai · 2003 · 4424 citations · Cited by this paper
  6. Endoscopic mucosal resection with precutting vs. anchoring technique using snare tip for 10–25 mm nonpedunculated colorectal polyps: a randomized controlled trial · 2026 · Related
  7. Mechanisms of NAFLD development and therapeutic strategies · Scott L. Friedman · 2018 · 4400 citations · Cited by this paper
  8. Risk factors and predictive model for transjugular intrahepatic portosystemic shunt dysfunction in cirrhotic patients · 2026 · Related
  9. Machine Learning in Medicine · Rahul C. Deo · 2015 · 3572 citations · Cited by this paper
  10. Fully covered metal stents as a risk factor for acute cholecystitis in patients with biliary stricture: a multicenter retrospective study · 2026 · Related
  11. A guide to machine learning for biologists · Joe G. Greener · 2021 · 2192 citations · Cited by this paper
  12. Paper Alert · 2026 · Related
  13. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) · Frank Tacke · 2024 · 2049 citations · Cited by this paper
  14. Interpretation of surgical recurrence in the dynamic phenotype of Crohn’s disease · 2026 · Related
  15. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease · Laurent Castéra · 2019 · 1518 citations · Cited by this paper
  16. Appendicectomy in active ulcerative colitis: is the evidence strong enough to support clinical recommendation? A critical appraisal · 2026 · Related
  17. Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis · Rod S. Taylor · 2020 · 1072 citations · Cited by this paper
  18. Safety of percutaneous gastrostomy tube placement in patients with cirrhosis: a multicenter matched cohort study · 2026 · Related
  19. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta‐analysis · Guangqin Xiao · 2017 · 906 citations · Cited by this paper
  20. Answer letter to ‘Methodological Limitations in Morphometric Assessment of Steatosis and Fibrosis in Metabolic Dysfunction–Associated Steatotic Liver Disease’, from Mahala Ali · 2026 · Related
  21. Epidemiology of metabolic dysfunction-associated steatotic liver disease · Zobair M. Younossi · 2024 · 876 citations · Cited by this paper
  22. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study · Philip Noel Newsome · 2020 · 800 citations · Cited by this paper
  23. Interpreting area under the receiver operating characteristic curve · Anne de Hond · 2022 · 519 citations · Cited by this paper
  24. Non-invasive diagnosis of liver fibrosis and cirrhosis · Yoav Lurie · 2015 · 358 citations · Cited by this paper
  25. AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis · Richard K. Sterling · 2024 · 155 citations · Cited by this paper
  26. Liver biopsy-based validation, confirmation and comparison of the diagnostic performance of established and novel non-invasive steatotic liver disease indexes: Results from a large multi-center study · Matina Kouvari · 2023 · 85 citations · Cited by this paper
  27. Non-Alcoholic Fatty Liver Disease: Implementing Complete Automated Diagnosis and Staging. A Systematic Review · Stefan‐Lucian Popa · 2021 · 37 citations · Cited by this paper
  28. NAFLD-related mortality: simple hepatic steatosis is not as ‘benign’ as thought · Herbert Tilg · 2020 · 35 citations · Cited by this paper
  29. The Impact of Nonalcoholic Fatty Liver Disease in Primary Care: A Population Health Perspective · Amr Dokmak · 2020 · 33 citations · Cited by this paper
  30. Non-invasive diagnosis of non-alcoholic fatty liver disease: Current status and future perspective · Jialan Wang · 2024 · 27 citations · Cited by this paper
  31. Validation of Non-invasive Fibrosis Scores for Predicting Advanced Fibrosis in Metabolic-associated Fatty Liver Disease · Xiaoning Chen · 2022 · 25 citations · Cited by this paper
  32. Noninvasive assessment of fibrosis among patients with nonalcoholic fatty liver disease [NAFLD] · David Eliot Bernstein · 2022 · 15 citations · Cited by this paper
  33. A machine learning-based predictive model discriminates nonalcoholic steatohepatitis from nonalcoholic fatty liver disease · Yuqi Yan · 2024 · 6 citations · Cited by this paper
  34. Untitled · Cited by this paper

Source: OpenAlex (CC0)